seen from Italy
seen from United States
seen from United States
seen from United States
seen from Yemen
seen from Italy
seen from United States
seen from United States
seen from China
seen from United States
seen from South Africa
seen from Netherlands
seen from United States
seen from United Kingdom
seen from United States
seen from United States
seen from South Africa
seen from United Kingdom
seen from Germany
seen from Australia
Cornerstone Acquires U.S Market Rights for PERTZYE
Cornerstone Therapeutics Inc. has entered into an agreement with Digestive Care Inc. to acquire the U.S. rights to market PERTZYE (pancrelipase) for the treatment of Exocrine Pancreatic Insufficiency (EPI) due to cystic fibrosis (CF).
View Post
